Table I.
Summary of clinical and histopathological patient data.
| A, Patient characteristics | |
|---|---|
| Characteristic | n (%) |
| No. of patients | 34 |
| Mean age ± standard deviation | 69.9±8.7 |
| Gender | |
| Male | 32 (94.1) |
| Female | 2 (5.9) |
| B, Patient anamnestic, pathological and clinical data | |
| Characteristic | n (%) |
| No. of recurrences/year | |
| 1 | 16 (47.1) |
| 2 | 9 (26.5) |
| ≥3 | 9 (26.5) |
| No. of lesions | |
| 1 | 21 (61.8) |
| 2 | 7 (20.6) |
| ≥3 | 6 (17.6) |
| Diameter of lesion (if multiple, diameter of the largest) | |
| <3 cm | 24 (70.6) |
| ≥3 cm | 10 (29.4) |
| Stage | |
| pT2 | 19 (55.9) |
| pT3a | 7 (20.6) |
| pT3b | 5 (14.7) |
| pT4 | 3 (8.8) |
| Grade | |
| G3 | 34 (100) |
| Lymph node involvement | |
| N0 | 28 (82.3) |
| N1 | 6 (17.7) |
| N2 | 0 (0.0) |
| N3 | 0 (0.0) |
| Previous intravesical therapy | 34 (100) |
| Cigarette smokers | 18 (52.9) |
| Charlson comorbidities index | |
| <2 | 26 (76.5) |
| 2 | 6 (17.6) |
| ≥3 | 2 (5.9) |
| Urinary diversion | |
| Cutaneous ureterostomy | 11 (32.4) |
| Ileal conduit | 6 (17.6) |
| Neobladder | 17 (50.0) |
| Mean no. of lymph nodes removed (range) | 15.1 (11–23) |
| Adjuvant chemotherapy | 3 (8.8) |
pT, primary tumour stage; G, grade; N, node involvement.